REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.46
-0.20 (-2.07%)
Aug 31, 2026, 1:08 PM EDT - Market open
REGENXBIO Employees
REGENXBIO had 371 employees as of December 31, 2025. The number of employees increased by 18 or 5.10% compared to the previous year.
Employees
371
Change (1Y)
18
Growth (1Y)
5.10%
Revenue / Employee
$470,302
Profits / Employee
-$529,466
Market Cap
624.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | 18 | 5.10% |
| Dec 31, 2024 | 353 | 9 | 2.62% |
| Dec 31, 2023 | 344 | -57 | -14.21% |
| Dec 31, 2022 | 401 | 29 | 7.80% |
| Dec 31, 2021 | 372 | 66 | 21.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Autolus Therapeutics | 754 |
| Valneva SE | 620 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| Verastem | 102 |
| OmniAb | 89 |
| AgomAb Therapeutics NV | 62 |
RGNX News
- 6 days ago - Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX) - Business Wire
- 6 days ago - Regenxbio price target lowered to $21 from $23 at H.C. Wainwright - TheFly
- 6 days ago - REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli - PRNewsWire
- 6 days ago - Regenxbio price target lowered to $29 from $32 at Baird - TheFly
- 6 days ago - Regenxbio price target lowered to $32 from $45 at Clear Street - TheFly
- 6 days ago - RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold - GlobeNewsWire
- 7 days ago - BofA says Regenxbio’s MPS setback ‘disappointing,’ larger catalysts intact - TheFly
- 7 days ago - Morning Movers: Regenxbio sinks following clinical hold on RGX-121 - TheFly